T-cell large granular lymphocyte leukemia and related disorders

Oncologist

Volumn 9, Issue 3, 2004, Pages 247-258

  Rose, Michal G ^a,b   Berliner, Nancy ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Chronic T cell leukemia; Felty's syndrome; Natural killer cell; Neutropenia

Indexed keywords

ALEMTUZUMAB; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; BETA 2 MICROGLOBULIN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FAS ANTIGEN; FAS LIGAND; FLUDARABINE; GRANULOCYTE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PENTOSTATIN; PREDNISONE; PURINE DERIVATIVE; STEROID; T LYMPHOCYTE RECEPTOR; THROMBOCYTE ANTIBODY; THYMOCYTE ANTIBODY;

ADULT; ANEMIA; ANTIBODY DETECTION; APLASTIC ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL FEATURE; CONTINUING EDUCATION; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; FELTY SYNDROME; FLOW CYTOMETRY; HASHIMOTO DISEASE; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPHENOTYPING; LARGE GRANULAR LYMPHOCYTE; LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; LEUKEMIA; NATURAL KILLER CELL; NEUTROPENIA; ONCOLOGY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PURE RED CELL ANEMIA; REVIEW; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LEUKEMIA; T CELL LYMPHOMA; THROMBOCYTOPENIA;

AGED; AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RED-CELL APLASIA, PURE;

EID: 2942627116     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-3-247     Document Type: Review

References (111)

1. McKenna RW, Parkin J, Kersey JH et al. Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics. Am J Med 1977;62:588-596.
2. Chan W, Catovsky D, Foucar K et al. T-cell large granular lymphocyte leukaemia. In: Jaffe E, Harris N, Stein H et al., eds. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2001:197-198.
3. Schwartz RS. Shattuck lecture: diversity of the immune repertoire and immunoregulation. N Engl J Med 2003;348:1017-1026. Erratum in: N Engl J Med 2003;348:2050.
4. Schwartz RS. Shattuck lecture: diversity of the immune repertoire and immunoregulation. N Engl J Med 2003;348:1017-1026. Erratum in: N Engl J Med 2003;348:2050.
5. Clayberger C, Kerensky A. T cell immunity. In: Hoffman R, Benz EJ, Shattil SJ et al., eds. Hematology: Basic Principles and Practice. Philadelphia: Churchill-Livingstone, 2000:90-100.
6. Gaulard P, Belhadj K, Reyes F. γδ T-cell lymphomas. Semin Hematol 2003;40:233-243.
7. Zambello R, Semenzato G. Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Semin Hematol 2003;40:201-212.
8. Moretta L, Bottino C, Pende D et al. Human natural killer cells: their origin, receptors and function. Eur J Immunol 2002;32:1205-1211.
9. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
10. Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia: report of 38 cases and review of the literature. Medicine (Baltimore) 1987;66:397-405.
11. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999;13:230-240.
12. Newland A, Catovsky D, Linch D et al. Chronic T cell lymphocytosis: a review of 21 cases. Br J Haematol 1984;58:433-446.
13. Oshimi K, Yamada O, Kaneko T et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7:782-788.
14. Berliner N. T gamma lymphocytosis and T cell chronic leukemias. Hematol Oncol Clin North Am 1990;4:473-487.
15. Bartlett NL, Longo DL. T-Small lymphocyte disorders. Semin Hematol 1999;36:164-170.
16. Dhodapkar MV, Li CY, Lust JA et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994;84:1620-1627.
17. Tefferi A, Li CY, Witzig TE et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994;84:2721-2725.
18. Loughran TP Jr, Clark EA, Price TH et al. Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood 1986;68:1082-1087.
19. Pandolfi F, Loughran TP Jr, Starkebaum G et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990;65:341-348.
20. + lymphocytes in HIV infection. J Clin Pathol 2000;53:177-181.
21. Kelemen E, Gergely P, Lehoczky D et al. Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity. Clin Exp Immunol 1986;63:696-702.
22. Mohty M, Faucher C, Vey N et al. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. Leukemia 2002;16:2129-2133.
23. Halwani F, Guttmann RD, Ste-Croix H et al. Identification of natural suppressor cells in long-term renal allograft recipients. Transplantation 1992;54:973-977.
24. Wong KF, Chan JC, Liu HS et al. Chromosomal abnormalities in T-cell large granular lymphocyte leukaemia: report of two cases and review of the literature. Br J Haematol 2002;116:598-600.
25. Loughran TP Jr, Kadin M, Starkebaum G et al. Leukemia of large granular lymphoctyes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985;102:169-175.
26. Hodges E, Krishna MT, Pickard C et al. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2003;56:1-11.
27. + large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 2001;159:1861-1868.
28. Posnett DN, Sinha R, Kabak S et al. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammopathy". J Exp Med 1994;179:609-618. Erratum in: J Exp Med 1994;179:1077.
29. Posnett DN, Sinha R, Kabak S et al. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammopathy". J Exp Med 1994;179:609-618. Erratum in: J Exp Med 1994;179:1077.
30. + T cell clones in elderly humans. J Immunol 1997;158:4493-4499.
31. Evans HL, Burks E, Viswanatha D et al. Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia. Hum Pathol 2000;31:1266-1273.
32. Morice WG, Kurtin PJ, Tefferi A et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 2002;99:268-274.
33. Agnarsson BA, Loughran TP Jr, Starkebaum G et al. The pathology of large granular lymphocyte leukemia. Hum Pathol 1989;20:643-651.
34. Loughran TP Jr, Starkebaum G, Clark E et al. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol 1987;67:135-140.
35. Richards S, Sivakumaran M, Parapia LA et al. A distinct large granular lymphocyte (LGL)/NK-associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpression. The Yorkshire Leukaemia Group. Br J Haematol 1992;82:494-501.
36. Vie H, Chevalier S, Garand R et al. Clonal expansion of lymphocytes bearing the γδ T-cell receptor in a patient with large granular lymphocyte disorder. Blood 1989;74:285-290.
37. Kothapalli R, Bailey RD, Kusmartseva I et al. Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 2003;22:33-39.
38. Loughran TP Jr, Hadlock KG, Perzova R et al. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998;101:318-324.
39. Liu J, Wei S, Lamy T et al. Chronic neutropenia mediated by fas ligand. Blood 2000;95:3219-3222.
40. Epling-Burnette PK, Liu JH, Catlett-Falcone R et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001;107:351-362.
41. Liu JH, Wei S, Lamy T et al. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 2002;100:1449-1453.
42. Saitoh T, Karasawa M, Sakuraya M et al. Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity. Eur J Haematol 2000;65:272-275.
43. Nagata S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J Hum Genet 1998;43:2-8.
44. Sneller MC, Dale JK, Straus SE. Autoimmune lymphoproliferative syndrome. Curr Opin Rheumatol 2003;15:417-421.
45. Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol 1998;51:672-675.
46. + T-cell large granular lymphocytosis: dependence on cyclosporin A therapy. Acta Haematol 1998;100:207-210.
47. Go RS, Li CY, Tefferi A et al. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001;98:483-485.
48. Maung ZT, Norden J, Middleton PG et al. Pure red cell aplasia: further evidence of T cell clonal disorder. Br J Haematol 1994;87:189-192.
49. Masuda M, Arai Y, Okamura T et al. Pure red cell aplasia (PRCA) with thymoma: a possible distinct clinical entity distinct from large granular lymphocyte (LGL) leukemia. Am J Hematol 2000;63:102-107.
50. Kondo H, Mori A, Watanabe J et al. Pure red cell aplasia associated with parvovirus B19 infection in T-large granular lymphocyte leukemia. Leuk Lymphoma 2001;42:1439-1443.
51. Ergas D, Resnitzky P, Berrebi A. Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia. Blood 1996;87:3523-3524.
52. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 2000;111:1010-1022.
53. Go RS, Tefferi A, Li CY et al. Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia. Blood 2000;96:3644-3646.
54. Young NS. Acquired aplastic anemia. Ann Intern Med 2002;136:534-546.
55. Gordon-Smith E, Marsh JC, Gibson FM. Views on the pathophysiology of aplastic anaemia. Int J Hematol 2002;76(suppl 2):163-166.
56. Saunthararajah Y, Molldrem JL, Rivera M et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001;112:195-200.
57. Kochenderfer JN, Kobayashi S, Wieder ED et al. Loss of T-lymphocyte clonal dominance in patients with myelodys-plastic syndrome responsive to immunosuppression. Blood 2002;100:3639-3645.
58. Molldrem JJ, Leifer E, Bahceci E et al. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann Intern Med 2002;137:156-163.
59. Papadaki T, Stamatopoulos K, Kosmas C et al. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases. Leukemia 2002;16:2167-2169.
60. Lesesve JF, Feugier P, Lamy T et al. Association of B-chronic lymphocytic leukaemia and T-large granular lymphocyte leukaemia. Clin Lab Haematol 2000;22:121-122.
61. +(dim) large granular lymphocytic leukemia, splenic B-cell lymphoma with circulating villous lymphocytes, and idiopathic erythrocytosis. Ann Hematol 2001;80:685-690.
62. Kingreen D, Dalal BI, Heyman M et al. Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease. Am J Hematol 1995;50:234-236.
63. Ergas D, Tsimanis A, Shtalrid M et al. T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjogren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia. Am J Hematol 2002;69:132-134.
64. Bowman SJ. Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 2002;31:251-259.
65. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 2002;39:121-127.
66. Coakley G. Sjogren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis. J Rheumatol 2002;29:1803; author reply 1803.
67. Molad Y, Okon E, Stark P et al. Sjogren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis. J Rheumatol 2001;28:2551-2552.
68. + T cell restriction. J Clin Endocrinol Metab 1997;82:1140-1146.
69. Felty A. Chronic arthritis in the adult, associated with splenomegaly and leucopenia. A report of five cases of an unusual clinical syndrome. Bull Johns Hopkins Hosp 1924;35:16-20.
70. Sibley JT, Haga M, Visram DA et al. The clinical course of Felty's syndrome compared to matched controls. J Rheumatol 1991;18:1163-1167.
71. Campion G, Maddison PJ, Goulding N et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore) 1990;69:69-80.
72. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361.
73. Freimark B, Lanier L, Phillips J et al. Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome. J Immunol 1987;138:1724-1729.
74. Gonzales-Chambers R, Przepiorka D, Winkelstein A et al. Lymphocyte subsets associated with T cell receptor beta-chain gene rearrangement in patients with rheumatoid arthritis and neutropenia. Arthritis Rheum 1992;35:516-520.
75. Loughran TP Jr, Starkebaum G, Kidd P et al. Clonal proliferation of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1988;31:31-36.
76. + T cell population of rheumatoid arthritis patients. J Immunol 1996;156:852-858.
77. Starkebaum G, Loughran TP Jr, Gaur LK et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997;40:624-626.
78. Natkunam Y, Wamke RA, Zehnder JL et al. Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation. Am J Clin Pathol 1999;111:663-671.
79. Macon WR, Williams ME, Greer JP et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996;87:1474-1483.
80. Gentile TC, Hadlock KG, Uner AH et al. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998;101:507-512.
81. Feher O, Barilla D, Locker J et al. T-cell large granular lymphocytic leukemia following orthotopic liver transplantation. Am J Hematol 1995;49:216-220.
82. + T cells with restricted T-cell receptor β chain variability after bone marrow transplantation. Blood 1994;83:587-595.
83. + T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Br J Haematol 1995;90:300-307.
84. Winton EF, Chan WC, Check I et al. Spontaneous regression of a monoclonal proliferation of large granular lymphocytes associated with reversal of anemia and neutropenia. Blood 1986;67:1427-1432.
85. Takeuchi M, Tamaoki A, Soda R et al. Spontaneous remission of large granular lymphocyte T cell leukemia. Leukemia 1999;13:313-314.
86. Semenzato G, Pandolfi F, Chisesi T et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987;60:2971-2978.
87. + lymphocytosis-associated neutropenia to G-CSF. Br J Haematol 1994;87:431-433.
88. Cooper DL, Henderson-Bakas M, Berliner N. Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor. Cancer 1993;72:1607-1611.
89. Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rheum 1999;29:82-99.
90. Loughran TP Jr, Kidd P, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994;84:2164-2170.
91. Hamidou MA, Sadr FB, Lamy T et al. Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis. Am J Med 2000;108:730-732.
92. Lust J, Letendre L, Thibodeau SN. Marrow hypoplasia associated with a monoclonal CD8 large granular lymphocyte proliferation: reversal with cyclophosphamide and prednisone. Am J Med 1989;87:214-217.
93. Sood R, Stewart CC, Aplan PD et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998;91:3372-3378.
94. Battiwala M, Sauntharajah Y, Nakamura R et al. Treatment of T-LGL (large granular lymphocytic disease) with cyclosporine A-long term follow-up. Blood 2002;100:669a.
95. Sternberg A, Eagleton H, Pillai N et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. Br J Haematol 2003;120:699-701.
96. Granjo E, Lima M, Correia T et al. CD8(+)/V beta 5.1 (+) large granular lymphocyte leukemia associated with autoimmune cytopenias, rheumatoid arthritis and vascular mammary skin lesions: successful response to 2-deoxycoformycin. Hematol Oncol 2002;20:87-93.
97. Mercieca J, Matutes E, Dearden C et al. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol 1994;12:2588-2593.
98. Ru X, Liebman HA. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol 2003;123:278-281.
99. + aggressive variant of large granular lymphocyte leukemia. Blood 1994;84:2315-2321.
100. Matutes E, Wotherspoon AC, Parker NE et al. Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. Br J Haematol 2001;115:801-806.
101. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000;14:991-997.
102. Wlodarska I, Martin-Garcia N, Achten R et al. Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 2002;33:243-251.
103. Chan J, Jaffe E, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe E, Harris N, Stein H et al., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001:204-207.
104. Chan J, Wong K, Jaffe E et al. Aggressive NK-cell leukaemia. In: Jaffe E, Harris N, Stein H et al., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001:198-200.
105. Chan JK, Sin VC, Wong KF et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-4513.
106. Cheung MM, Chan JK, Wong KF. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol 2003;40:221-232.
107. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996;87:1466-1473.
108. Imamura N, Kusunoki Y, Kawa-Ha K et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol 1990;75:49-59.
109. Cheung MM, Chan JK, Lau WH et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70-77.
110. Cheung MM, Chan JK, Lau WH et al. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002;54:182-190.
111. Rabbani GR, Phyliky RL, Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 1999;106:960-966.